Truist Securities Reiterates Buy Rating on Globus Medical, Inc. (GMED)

Market Context

Globus Medical, Inc. operates in the Healthcare sector. The stock currently trades at $80.91 with a market capitalization of $11.9B. The stock has gained 36.9% over the past 52 weeks.

Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Globus Medical, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Globus Medical, Inc.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 16, 2026	Truist Securities	Buy	N/A
Jul 13, 2026	RBC Capital	Outperform	N/A
Jul 09, 2026	BMO Capital	Outperform	N/A
Jul 08, 2026	Stifel	Hold	N/A
Jun 15, 2026	Piper Sandler	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View GMED Stock Page